Evidence map›Paper›PMID 23649778›Full record

ArticleJournal of the American Society for Mass Spectrometry2013

Evaluation of selected binding domains for the analysis of ubiquitinated proteomes.

Ernesto S Nakayasu, Charles Ansong, Joseph N Brown, Feng Yang, Daniel Lopez-Ferrer, Wei-Jun Qian, Richard D Smith, Joshua N Adkins

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Society for Mass Spectrometry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ernesto S NakayasuBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99352, USA.
Charles Ansong
Joseph N Brown
Feng Yang
Daniel Lopez-Ferrer
Wei-Jun Qian
Richard D Smith
Joshua N Adkins
Pacific Northwest National Laboratory · US

Funding

WORKSHOP AND TRAINING ACTIVITIESP41RR018522 · NCRR · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SMITH, RICHARD D · 2003 to 2011
$25.1M
Equipment Supplement Request for a Research Resource for Ultra-sensitive High Throughput ProteomicsP41GM103493 · NIGMS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SMITH, RICHARD D · 2012 to 2022
$22.6M
Consortia for High-Throughput-Enabled Structural Biology Partnerships (U01)U01GM094623 · NIGMS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI ADKINS, JOSHUA N. · 2010 to 2014
$5.2M
SURFACE CHEMISTRY OF MYCOBACTERIAR01AI008401 · NIAID · NATIONAL JEWISH HEALTH · PI GOREN, MAYER B. · 1989 to 1989
–
SURFACE CHEMISTRY OF MYCOBACTERIAR22AI008401 · NIAID · NATIONAL JEWISH HEALTH · PI GOREN, MAYER B. · 1985 to 1989
–
NCRR NIH HHS 5P41RR018522-10NCRR NIH HHS P41 RR018522NIAID NIH HHS Y01 AI008401NIAID NIH HHS Y1-AI-4894-01NIGMS NIH HHS 8 P41 GM103493-10NIGMS NIH HHS GM094623NIGMS NIH HHS P41 GM103493NIGMS NIH HHS U01 GM094623
6 · The paper itself

Abstract

Ubiquitination is an abundant post-translational modification that consists of covalent attachment of ubiquitin to lysine residues or the N-terminus of proteins. Mono- and polyubiquitination have been shown to be involved in many critical eukaryotic cellular functions and are often disrupted by intracellular bacterial pathogens. Affinity enrichment of ubiquitinated proteins enables global analysis of this key modification. In this context, the use of ubiquitin-binding domains is a promising but relatively unexplored alternative to more broadly used immunoaffinity or tagged affinity enrichment methods. In this study, we evaluated the application of eight ubiquitin-binding domains that have differing affinities for ubiquitination states. Small-scale proteomics analysis identified ~200 ubiquitinated protein candidates per ubiquitin-binding domain pull-down experiment. Results from subsequent Western blot analyses that employed anti-ubiquitin or monoclonal antibodies against polyubiquitination at lysine 48 and 63 suggest that ubiquitin-binding domains from Dsk2 and ubiquilin-1 have the broadest specificity in that they captured most types of ubiquitination, whereas the binding domain from NBR1 was more selective to polyubiquitination. These data demonstrate that with optimized purification conditions, ubiquitin-binding domains can be an alternative tool for proteomic applications. This approach is especially promising for the analysis of tissues or cells resistant to transfection, of which the overexpression of tagged ubiquitin is a major hurdle.

Indexed as

Adaptor Proteins, Signal TransducingAdaptor Proteins, Vesicular TransportAmino Acid SequenceAnimalsAntibodies, MonoclonalAutophagy-Related ProteinsBlotting, WesternCell Cycle ProteinsCell LineChromatography, AffinityElectrophoresis, Polyacrylamide GelHydrolysisImmunochemistryIndicators and ReagentsInflammationMacrophagesAdaptor Proteins, Signal TransducingAdaptor Proteins, Vesicular TransportAntibodies, MonoclonalAutophagy-Related ProteinsCell Cycle ProteinsDSK2 protein, S cerevisiaeIndicators and ReagentsProteomeSaccharomyces cerevisiae ProteinsUbiquitinated ProteinsUbiquitinsUBQLN1 protein, mouse

Identifiers

PMID23649778
PMCPMC3715598
OpenAlexW2020428698

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.